Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Blazey

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Bioorganic & Medicinal Chemistry Letters|March 28, 2012
Pyrazolopyrimidines as dual Akt/p70S6K inhibitorsKenneth D Rice, Moon H Kim, Joerg Bussenius, et al.
Bioorganic & Medicinal Chemistry Letters|February 21, 2012
Design and evaluation of a series of pyrazolopyrimidines as p70S6K inhibitorsJoerg Bussenius, Neel K Anand, Charles M Blazey, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 13, 2018
Utility of perfusion PET measures to assess neuronal injury in Alzheimer's diseaseNelly Joseph-Mathurin, Yi Su, Tyler M Blazey, et al.
Brain : a Journal of Neurology|February 13, 2019
Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkersBrian A Gordon, Tyler M Blazey, Jon Christensen, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2012
Discovery of XL888: a novel tropane-derived small molecule inhibitor of HSP90Joerg Bussenius, Charles M Blazey, Naing Aay, et al.
Plos One|March 25, 2016
Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study GroupYi Su, Tyler M Blazey, Christopher J Owen, et al.
Plos One|September 21, 2016
Correction: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study GroupYi Su, Tyler M Blazey, Christopher J Owen, et al.
JAMA Neurology|July 30, 2014
Functional connectivity in autosomal dominant and late-onset Alzheimer diseaseJewell B Thomas, Matthew R Brier, Randall J Bateman, et al.
The Lancet. Neurology|February 5, 2018
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal studyBrian A Gordon, Tyler M Blazey, Yi Su, et al.
Neurology|January 26, 2021
Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer DiseaseNelly Joseph-Mathurin, Guoqiao Wang, Kejal Kantarci, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Bioorganic & Medicinal Chemistry Letters|March 28, 2012
Pyrazolopyrimidines as dual Akt/p70S6K inhibitorsKenneth D Rice, Moon H Kim, Joerg Bussenius, et al.
Bioorganic & Medicinal Chemistry Letters|February 21, 2012
Design and evaluation of a series of pyrazolopyrimidines as p70S6K inhibitorsJoerg Bussenius, Neel K Anand, Charles M Blazey, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 13, 2018
Utility of perfusion PET measures to assess neuronal injury in Alzheimer's diseaseNelly Joseph-Mathurin, Yi Su, Tyler M Blazey, et al.
Brain : a Journal of Neurology|February 13, 2019
Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkersBrian A Gordon, Tyler M Blazey, Jon Christensen, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2012
Discovery of XL888: a novel tropane-derived small molecule inhibitor of HSP90Joerg Bussenius, Charles M Blazey, Naing Aay, et al.
Plos One|March 25, 2016
Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study GroupYi Su, Tyler M Blazey, Christopher J Owen, et al.
Plos One|September 21, 2016
Correction: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study GroupYi Su, Tyler M Blazey, Christopher J Owen, et al.
JAMA Neurology|July 30, 2014
Functional connectivity in autosomal dominant and late-onset Alzheimer diseaseJewell B Thomas, Matthew R Brier, Randall J Bateman, et al.
The Lancet. Neurology|February 5, 2018
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal studyBrian A Gordon, Tyler M Blazey, Yi Su, et al.
Neurology|January 26, 2021
Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer DiseaseNelly Joseph-Mathurin, Guoqiao Wang, Kejal Kantarci, et al.
Pageof 3